S2 Episode 5: HIV, Primary Care Treatment, and Vaccines S2 Episode 5: HIV, Primary Care Treatment, and Vaccines
Drs Michael S. Saag and David H. Spach discuss HIV and the nuances of primary care treatment, with a special focus on vaccines, including COVID, hepatitis, varicella zoster virus, and mpox.Medscape (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 13, 2023 Category: Infectious Diseases Tags: HIV/AIDS InDiscussion Source Type: news
Hepatitis B Vaccination Rates Lag in Patients With Psoriasis Hepatitis B Vaccination Rates Lag in Patients With Psoriasis
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 27, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Is A Broadly Protective And Long Lasting Hepatitis C Vaccine Possible?
Current understanding of the hepatitis C virus requires that a vaccine be both broadly protective and long lasting. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 15, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
US issues 3 recalls for hepatitis A in strawberries imported from Mexico - how is it spreading?
Frozen strawberries imported from Mexico have been recalled several times in the US within the past several months for possible hepatitis A. Lack of vaccinations in Mexico could lead to this spread. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2023 Category: Consumer Health News Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Investor Update - June 13, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Media News - June 13, 2023 Category: Pharmaceuticals Source Type: news
There's No Hepatitis C Vaccine, But You Can Still Prevent Infection
MONDAY, June 12, 2023 -- Hepatitis C can ruin your liver, and there ' s no vaccine to prevent it, but you can take steps to lower your chances of infection.
According to the U.S. Centers for Disease Control and Prevention, over 2 million U.S. adults... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2023 Category: General Medicine Source Type: news
Hepatitis A: outbreak information, UKHSA (updated 25th May 2023)
Information about the risks, symptoms and how to seek treatment for hepatitis A.
25 May 2023Added video on hepatitis A risks, symptoms and vaccination.
19 May 2022Added links to translated versions. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 26, 2023 Category: Consumer Health News Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
Africa: 'Vaccinate Against Deadly Diseases Including Covid-19'
[ADAPT] African Vaccination Week is a crucial reminder of the life-saving power of vaccines. From COVID-19 to polio, diphtheria, tetanus, hepatitis B, influenza, rotavirus, measles, and the human papillomavirus (HPV), vaccines offer protection against deadly diseases. With this week falling on the last week of April, there is no better time to prioritize vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 25, 2023 Category: African Health Source Type: news
ACIP 2023 Recommended Immunization Schedule for Adults ACIP 2023 Recommended Immunization Schedule for Adults
Review vaccine-specific changes in the 2023 immunization schedule for adults aged 19 years and older, including updates to influenza, hepatitis B, and pneumococcal vaccination.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 24, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
The Unique Challenges of the Fentanyl Epidemic
The U.S. Centers for Disease Control and Prevention (CDC) estimates that 107,477 drug-related deaths occurred from August 2021 to August 2022, with the majority attributed to the potent synthetic opioid, fentanyl. These provisional estimates reflect a modest (2.57%) decrease from the previous year, defying an increasing trend that has persisted for the last 20 years where opioids have been the primary driver of overdose deaths. Through its evolutions, the current opioid epidemic has proven to be an ever-moving target, and there’s much we still need to learn in order to curb fentanyl exposure and overdose.
The origins...
Source: TIME: Health - April 6, 2023 Category: Consumer Health News Authors: Jermaine Jones Tags: Uncategorized freelance health Source Type: news
Study provides insights into child hepatitis outbreak
A global outbreak of child hepatitis has been linked to a common virus combined with an underlying genetic predisposition, a new study has suggested. Researchers at the Universities of Edinburgh and Glasgow have conducted the first detailed investigation into the cause of the recent hepatitis outbreak. The findings, published in Nature, strongly suggest that the... Read moreThe post Study provides insights into child hepatitis outbreak appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - April 5, 2023 Category: Nursing Authors: Carolyn Scott Tags: Paediatrics Vaccinations and infections AAV2 virus child hepatitis Source Type: news
